Congress Asset Management Co. Acquires 62,411 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Congress Asset Management Co. boosted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 7.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 865,123 shares of the company's stock after buying an additional 62,411 shares during the period. Congress Asset Management Co. owned 1.74% of Prestige Consumer Healthcare worth $62,375,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Opal Wealth Advisors LLC purchased a new stake in Prestige Consumer Healthcare during the second quarter valued at about $26,000. Quest Partners LLC raised its position in Prestige Consumer Healthcare by 2,826.7% during the second quarter. Quest Partners LLC now owns 439 shares of the company's stock valued at $30,000 after acquiring an additional 424 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Prestige Consumer Healthcare by 80.6% during the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in Prestige Consumer Healthcare by 562.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company's stock valued at $35,000 after purchasing an additional 433 shares during the last quarter. Finally, Gladius Capital Management LP acquired a new position in Prestige Consumer Healthcare during the second quarter valued at approximately $35,000. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Up 0.3 %

PBH stock traded up $0.19 during midday trading on Thursday, reaching $73.75. The stock had a trading volume of 237,280 shares, compared to its average volume of 245,685. The business has a fifty day simple moving average of $72.06 and a two-hundred day simple moving average of $69.49. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The firm has a market cap of $3.66 billion, a price-to-earnings ratio of 17.99, a PEG ratio of 2.06 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business had revenue of $267.10 million during the quarter, compared to analyst estimates of $260.54 million. During the same period in the previous year, the firm earned $1.06 EPS. Prestige Consumer Healthcare's quarterly revenue was down 4.4% compared to the same quarter last year. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a "buy" rating in a research note on Wednesday, August 28th. Jefferies Financial Group reissued a "hold" rating and set a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $94.20.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.